AGC Biologics is a global contract-development and manufacturing organization (CDMO) that supports biopharmaceutical companies through every stage of bringing a therapy to market. The company develops and manufactures a wide range of products, including therapeutic proteins, cell and gene therapies, plasmid DNA, mRNA, and viral vectors. With facilities across the United States, Europe, and Asia, AGC Biologics provides end-to-end capabilities such as cell line development, process optimization, analytical testing, formulation, and GMP manufacturing. Its model is built around being a single-partner solution, helping biotech innovators move efficiently from early research to clinical trials and commercial production.